Phase Ib study of dovitinib in combination with gemcitabine plus cisplatin or gemcitabine plus carboplatin in patients with advanced solid tumors
作者： Matthew D. Galsky , Marshall Posner , Randall F. Holcombe , Karen M. Lee , Krzysztof Misiukiewicz
DOI: 10.1007/S00280-014-2518-5
关键词:
摘要: Purpose Dovitinib is a small molecule kinase inhibitor with activity against the fibroblast growth factor and vascular endothelial receptor families. The purpose of this phase Ib study was to define recommended 2 dose combinations gemcitabine cisplatin or carboplatin plus dovitinib.
springer.com
sci-hub.se 参考文章(34)
Debashis Sarker, Rhoda Molife, T.R. Jeffrey Evans, Maryon Hardie, Cheryl Marriott, Priska Butzberger-Zimmerli, Rosemary Morrison, Judith A. Fox, Carla Heise, Sharianne Louie, Natasha Aziz, Felix Garzon, Glenn Michelson, Ian R. Judson, Dalal Jadayel, Edgar Braendle, Johann S. de Bono, A Phase I Pharmacokinetic and Pharmacodynamic Study of TKI258, an Oral, Multitargeted Receptor Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumors Clinical Cancer Research. ,vol. 14, pp. 2075- 2081 ,(2008) , 10.1158/1078-0432.CCR-07-1466
Toni K. Choueiri, Fabio A.B. Schutz, Youjin Je, Jonathan E. Rosenberg, Joaquim Bellmunt, Risk of Arterial Thromboembolic Events With Sunitinib and Sorafenib: A Systematic Review and Meta-Analysis of Clinical Trials Journal of Clinical Oncology. ,vol. 28, pp. 2280- 2285 ,(2010) , 10.1200/JCO.2009.27.2757
Matthew D. Galsky, Noah M. Hahn, Thomas Powles, Beth A. Hellerstedt, Seth P. Lerner, Thomas A. Gardner, Menggang Yu, Mark O'Rourke, Nicholas J. Vogelzang, Darren Kocs, Scott A. McKenney, Anton M. Melnyk, Thomas E. Hutson, Mary Rauch, Yunfei Wang, Lina Asmar, Guru Sonpavde, Gemcitabine, Cisplatin, and sunitinib for metastatic urothelial carcinoma and as preoperative therapy for muscle-invasive bladder cancer. Clinical Genitourinary Cancer. ,vol. 11, pp. 175- 181 ,(2013) , 10.1016/J.CLGC.2012.10.001
Tracy Proverbs-Singh, Sophia K. Chiu, Ziyue Liu, Sonia Seng, Guru Sonpavde, Toni K. Choueiri, Che-Kai Tsao, Menggang Yu, Noah M Hahn, William K. Oh, Matthew D. Galsky, Arterial Thromboembolism in Cancer Patients Treated With Cisplatin: A Systematic Review and Meta-analysis Journal of the National Cancer Institute. ,vol. 104, pp. 1837- 1840 ,(2012) , 10.1093/JNCI/DJS435
Eric Angevin, Jose A. Lopez-Martin, Chia-Chi Lin, Jürgen E. Gschwend, Andrea Harzstark, Daniel Castellano, Jean-Charles Soria, Paramita Sen, Julie Chang, Michael Shi, Andrea Kay, Bernard Escudier, Phase I Study of Dovitinib (TKI258), an Oral FGFR, VEGFR, and PDGFR Inhibitor, in Advanced or Metastatic Renal Cell Carcinoma Clinical Cancer Research. ,vol. 19, pp. 1257- 1268 ,(2013) , 10.1158/1078-0432.CCR-12-2885
Fabrice Andre, Suzette Delaloge, Jean-Charles Soria, Biology-Driven Phase II Trials: What Is the Optimal Model for Molecular Selection? Journal of Clinical Oncology. ,vol. 29, pp. 1236- 1238 ,(2011) , 10.1200/JCO.2010.31.6877
Maria Teresa Herrera-Abreu, Alex Pearson, James Campbell, Steve D Shnyder, Margaret A Knowles, Alan Ashworth, Nicholas C Turner, None, Parallel RNA interference screens identify EGFR activation as an escape mechanism in FGFR3 mutant cancer Cancer Discovery. ,vol. 3, pp. 1058- 1071 ,(2013) , 10.1158/2159-8290.CD-12-0569
Alicia S Chung, John Lee, Napoleone Ferrara, None, Targeting the tumour vasculature: insights from physiological angiogenesis Nature Reviews Cancer. ,vol. 10, pp. 505- 514 ,(2010) , 10.1038/NRC2868
Wei-Tien Tai, Ann-Lii Cheng, Chung-Wai Shiau, Chun-Yu Liu, Ching-Huai Ko, Mai-Wei Lin, Pei-Jer Chen, Kuen-Feng Chen, Dovitinib Induces Apoptosis and Overcomes Sorafenib Resistance in Hepatocellular Carcinoma through SHP-1–Mediated Inhibition of STAT3 Molecular Cancer Therapeutics. ,vol. 11, pp. 452- 463 ,(2012) , 10.1158/1535-7163.MCT-11-0412
Impact of tumour size on metastases and locally advanced growth in renal cell carcinoma up to 7 cm BJUI. ,vol. 109, pp. 7- 7 ,(2012) , 10.1111/J.1464-410X.2012.11171.X